Horobin Joanna - Insider Non-Derivative Transactions at Kymera Therapeutics, Inc. (KYMR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 7, 2024, Horobin Joanna's relationship to Kymera Therapeutics, Inc. (KYMR) is Director, and currently has 8,500 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KYMR insiders.
Data Source: SEC.
Horobin Joanna - Insider Non-Derivative Transactions at KYMR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 8, 2024 | Sell -- (Common Stock) | 6313 | 33.11 | 0 |
| Jun 8, 2024 | Sell -- (Common Stock) | 2187 | 32.65 | 6313 |
| Jun 8, 2024 | M -- (Common Stock) | 8500 | 2.08 | 8500 |